Ansu Noronha

503 total citations
20 papers, 390 citations indexed

About

Ansu Noronha is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, Ansu Noronha has authored 20 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Genetics and 7 papers in Immunology. Recurrent topics in Ansu Noronha's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (5 papers) and Herpesvirus Infections and Treatments (3 papers). Ansu Noronha is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (5 papers) and Herpesvirus Infections and Treatments (3 papers). Ansu Noronha collaborates with scholars based in United States, India and United Kingdom. Ansu Noronha's co-authors include Francis A. Farraye, Yanmei Liang, B. G. W. Arnason, D. Goldstein, Neil H. Pliskin, Vernon L. Towle, Lisa Ganley‐Leal, Anthony T. Reder, Sharmeel K. Wasan and Jason Reich and has published in prestigious journals such as Gastroenterology, Neurology and The American Journal of Gastroenterology.

In The Last Decade

Ansu Noronha

20 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ansu Noronha United States 10 118 112 92 84 54 20 390
Seray Külcü Çakmak Türkiye 15 108 0.9× 83 0.7× 60 0.7× 165 2.0× 125 2.3× 87 693
Arzu Kılıç Türkiye 15 122 1.0× 99 0.9× 54 0.6× 159 1.9× 128 2.4× 84 701
Annamaria Pasi Italy 13 213 1.8× 110 1.0× 47 0.5× 168 2.0× 36 0.7× 27 533
U Skansén-Saphir Sweden 8 309 2.6× 83 0.7× 38 0.4× 98 1.2× 55 1.0× 8 615
G.M. Kavanagh United Kingdom 13 102 0.9× 142 1.3× 33 0.4× 140 1.7× 116 2.1× 34 488
Hamdi Özcan Türkiye 13 87 0.7× 35 0.3× 22 0.2× 77 0.9× 45 0.8× 26 448
Henrik Jacobsen Denmark 11 95 0.8× 47 0.4× 62 0.7× 82 1.0× 23 0.4× 29 442
Fatih Göktay Türkiye 14 50 0.4× 79 0.7× 52 0.6× 216 2.6× 102 1.9× 58 480
Hana Golan Israel 12 119 1.0× 19 0.2× 54 0.6× 54 0.6× 17 0.3× 32 405
A. Yasmine Kirkorian United States 10 39 0.3× 74 0.7× 18 0.2× 71 0.8× 36 0.7× 52 372

Countries citing papers authored by Ansu Noronha

Since Specialization
Citations

This map shows the geographic impact of Ansu Noronha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ansu Noronha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ansu Noronha more than expected).

Fields of papers citing papers by Ansu Noronha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ansu Noronha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ansu Noronha. The network helps show where Ansu Noronha may publish in the future.

Co-authorship network of co-authors of Ansu Noronha

This figure shows the co-authorship network connecting the top 25 collaborators of Ansu Noronha. A scholar is included among the top collaborators of Ansu Noronha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ansu Noronha. Ansu Noronha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reich, Jason, et al.. (2020). Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 65(10). 2986–2991. 27 indexed citations
2.
Qazi, Taha, Alexander Smith, Megan Alexander, et al.. (2020). Disparities in Objective Sleep Quality as Assessed Through Wrist Actigraphy in Minority Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 27(3). 371–378. 2 indexed citations
3.
Reich, Jason, Andrew Canakis, Janice Weinberg, et al.. (2019). The Use of An EHR Patient Portal (Mychart-Epic) in Patients With Inflammatory Bowel Disease. Crohn s & Colitis 360. 1(3). 13 indexed citations
4.
Shin, Donghoon, et al.. (2019). Imaging of Gastrointestinal Tract Perforation. Radiologic Clinics of North America. 58(1). 19–44. 13 indexed citations
5.
Reich, Jason, et al.. (2019). Su1932 – Safety of Recombinant Zoster Vaccine (Rzv-Shingrix) in Patients with Inflammatory Bowel Disease. Gastroenterology. 156(6). S–665. 1 indexed citations
6.
Zullow, Samantha, et al.. (2018). Mo1875 - Efficacy of Ustekinumab in Patients with Refractory Perianal Crohn's Disease in a Tertiary Care IBD Center. Gastroenterology. 154(6). S–834. 3 indexed citations
7.
Farraye, Francis A., et al.. (2018). Successful Transition to an Infliximab Biosimilar at an Academic Hospital. The American Journal of Gastroenterology. 113(Supplement). S655–S656. 2 indexed citations
8.
Reich, Jason, et al.. (2018). Use of Recombinant Zoster Vaccine (RZV-Shingrix) in Patients With Inflammatory Bowel Disease. The American Journal of Gastroenterology. 113(Supplement). S400–S400. 2 indexed citations
9.
Wasan, Sharmeel K., et al.. (2016). Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in a Large Tertiary Medical Center. The American Journal of Gastroenterology. 111. S270–S270. 3 indexed citations
10.
Reich, Jason, Hannah L. Miller, Sharmeel K. Wasan, et al.. (2015). Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease.. PubMed Central. 11(6). 396–401. 24 indexed citations
11.
12.
Reich, Jason, Sharmeel K. Wasan, Hannah L. Miller, et al.. (2014). A Quality Improvement Intervention Significantly Improved Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease (IBD). The American Journal of Gastroenterology. 109. S640–S641. 1 indexed citations
13.
Beal, Dominic R., Yanmei Liang, Ansu Noronha, et al.. (2013). B Cells Secrete Eotaxin-1 in Human Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 19(5). 922–933. 18 indexed citations
14.
McDonnell, Marie E., Yanmei Liang, Ansu Noronha, et al.. (2010). Systemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflammatory Bowel Diseases. 17(1). 298–307. 50 indexed citations
15.
Liang, Yanmei, Hatice Hastürk, Jennifer Elliot, et al.. (2010). Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells. Clinical Immunology. 138(1). 33–40. 32 indexed citations
16.
Noronha, Ansu, Yanmei Liang, Jeremy T. Hetzel, et al.. (2009). Hyperactivated B cells in human inflammatory bowel disease. Journal of Leukocyte Biology. 86(4). 1007–1016. 61 indexed citations
17.
Noronha, Ansu, Yanmei Liang, Francis A. Farraye, et al.. (2009). S1727 TLR2 Regulates B Cell Response and Function in Inflammatory Bowel Disease. Gastroenterology. 136(5). A–258. 1 indexed citations
18.
Hull, D., et al.. (2007). Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold.. PubMed. 27(2). 73–7. 14 indexed citations
19.
Hilberg, Ole, et al.. (2000). Nasal histamine challenge: a reproducible model of induced congestion measured by acoustic rhinometry.. PubMed. 16. 45–50. 8 indexed citations
20.
Pliskin, Neil H., D. Goldstein, Vernon L. Towle, et al.. (1996). Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology. 47(6). 1463–1468. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seray Külcü Çakmak Breakdown of academic impact, for papers by Arzu Kılıç Breakdown of academic impact, for papers by Annamaria Pasi Breakdown of academic impact, for papers by U Skansén-Saphir Breakdown of academic impact, for papers by G.M. Kavanagh Breakdown of academic impact, for papers by Hamdi Özcan Breakdown of academic impact, for papers by Henrik Jacobsen Breakdown of academic impact, for papers by Fatih Göktay Breakdown of academic impact, for papers by Hana Golan Breakdown of academic impact, for papers by A. Yasmine Kirkorian
Rankless by CCL
2026